The past year has seen a wider application of knowledge originating over the last decade rather than startling new developments. For brevity, only serum enzymes will be considered and the points at which progress is being made are indicated by the sectional headings which follow.
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ENZYME METHODOLOGY
Considerable change is taking place in established enzyme methods and new forms of methodology are being developed.
Colorimetric kinetic assays
Together with the familiar ultraviolet (UY) kinetic assays, newer kinetic assays utilising wavelengths in the visible part of the spectrum are proving increasingly popular. They have been rendered possible by the increasing availability of chromogenic enzyme substrates. Examples are listed in Table 1 . Their advantages are:
1. No reagent addition is required to stop the reaction. Therefore there is no dilution of product; the amount of product to be measured is small and the amount of sample is small. 2. They are highly sensitive and therefore rapid. 3. Since sample size is small, there is minimal effect of activators or inhibitors added with the sample. 4. Sample blanks are not required. 5. Incubation timing errors are avoided, hence accuracy increased. 6. Linearity of enzyme reaction can be monitored. 7. Methodology is simple and suitable for semiautomation. 8. Highly active sera may be measured without dilution so avoiding dilution effects (i.e. effect of sample on substrate pH, inhibitor or activator concentration). On the other hand the following disadvantages should be guarded against:
1. Chromogenic enzyme substrates may not yield diagnostic information identical with that obtained using standard methods.
2. Substrate blanks are required to check spontaneous substrate hydrolysis. 3. Initial reaction rates should be measured unless there is a lag phase. 4. The reaction progress curve should be linear. 5. The Colorimeter must be suitable and accurately calibrated. 6. Enzyme substrate concentrations should, where possible, be optimal and enzyme activators need to be added since these may not be adequately provided by the small sample. (Frajola et al., 1965; phosphate Hausamen et al., 1967) Leucine aminopep-L-Ieucyl-p-p-nitroaniline 405 nm Obstructive liver tidase nitroanilide disease (Szasz, 1967) Cholinesterase acetylthiocholine thiocholine 405 nm Liver disease (espec- (Ellman et al., 1961: 1+ ially hepatocellular) Weber, 1966) 5:5' dithiobis-Suxamethonium sensit-(2-nitrobenzoate) ivity 5-mercapto-2-Organophosphorus nitro-benzoate poisoning Paper rcad at Southern England and South Wales Regional Meeting, London, March, 1969.
Enzyme determinations using the Berthelot (indophenol) reaction
The Berthelot Reaction for ammonia (Berthelot, 1859) has become familiar in the clinical laboratory because of its application to the determination of blood urea. The reaction may be used to measure enzyme activity where ammonia is formed as a direct reaction product, or is yielded by a coupled indicator enzyme reaction. Enzyme activities which may be determined in this manner are shown in Table 2 .
Tetrazolium methods
Reduction-oxidation dyes, particularly the tetrazolium salts, may be used for colorimetric assay of the majority of clinically important nicotinamideadenine dinucleotide (NAD) or nicotinamideadenine dinucleotide phosphate (NADP) dependent dehydrogenase enzymes. In addition, they may be applied to the determination of other diagnostic enzymes (e.g. the transaminases). Reduced NAD (NADH.) or reduced NADP (NADPH.) formed as a result of dehydrogenase action reduces a tetrazolium salt to a coloured formazan, phenazine methosulphate (PMS) serving as an intermediate electron carrier (Nachlas et al., 1960; Raabo, 1963; Babson and Phillips, 1965) .
. In .e~me reactions where NADH. or NADPH. IS oxidised, the NADH. or NADPH. remaining at the end of incubation may be determined (Whitaker 1969) . ' The advantages of tetrazolium methods are: 1. They use simple colorimetry. 2. Technically they are simple, requiring few manipulations, short procedure times and are readily automated. 3. They are economical of reagents. 4. Generally they use NAD rather than NADH avoiding the problem of inhibitors in NADII'
. I preparations and also the endogenous oxidation of NADH. by serum oxo-acids and enzyme in the absence of added substrate. 5. Optimal substrate concentrations can be used unlike some colorimetric dehydrogenase pro: cedures in which substrate concentration is limited by the colour of the oxo-acid hydrazone. Therefore calibration curves can be linear'
kin~t~~s can be zero-order, and sera with hiã ctivities can be measured using shortened incubation time; and there is no substrate exhaustion with loss of zero-order kinetics with highly active sera. 6. Colour formation rather than the disappearance of colour is measured, avoiding inaccuracy due to measurement of small decreases in optical density (O.D.) compared with high blank O.D. with sera of low activity. 7. Colour formation may be visually monitored during incubation, enabling highly active sera to be recognised and the incubation time to be shortened. On the other hand there are disadvantages: 1. Reagents must be protected from light. 2. Reagent and final colour stability may be very limited. (Martinek, 1963) Guanase Guanine Xanthine + NH. Hepatocellulardisease (Caraway, 1966) Ornithine trans-Citrulline Ornithine + NH. Liver disease (especially carbamylase hepatocellular) (Konttinen, 1967) 5'-nucleotidase Adenosine-S'-Adenosine Obstructiveliver (Persijn et al., 
3. Degree of formazan formation varies with different dye batches. Therefore each dye batch must be individually calibrated. 4. Calibration requires reduced co-enzyme solutions or enzyme reference solutions (control sera).
Diazo coupling methods
Azo coupling techniques have long been in use for the determination of the isoenzymes of hydrolytic enzymes (e.g, the phosphatases and aminopeptidases) separated by electrophoresis (Lawrence, Melnick, and Weimer, 1960) . Isoenzymes show as coloured bands in the support medium when this is incubated with a suitable substrate (generally a naphthol derivative) and azo dye.
Coupling techiques have more recently also been applied to the determination of total enzyme activity. Of the hydrolytic enzymes only acid phosphatase is commonly determined by diazo coupling, anaphthyl phosphate serving as substrate (Babson and Phillips, 1966) . The technique is simple and rapid, and this substrate is more specific for prostatic acid phosphatase than is phenylphosphate.
A diazo coupling technique has also proved very satisfactory for serum glutamate-oxaloacetate transaminase (SGOT) determination: the azo dye coupling with oxaloacetate formed by the action of the enzyme on aspartate and a-oxoglutarate (Babson et al., 1962) . The diazo SGOT technique is faster than the colorimetric Reitman-Frankel procedure for SGOT (Reitman and Frankel, 1957) and permits the use of a higher and more optimal concentration of n-oxoglutarate in the substrate. It may also be adapted to SGOT isoenzyme visualisation following electrophoresis.
Isoenzyme methods
Procedures available for isoenzyme separation and demonstration, and current clinical applications of isoenzyme measurement have been reviewed by the author elsewhere (Rosalki, 1968) . Here mention will only be made of the continuing clinical interest in lactate dehydrogenase (L.D.) and alkaline phosphatase isoenzymes, and the increasing popularity of procedures other than electrophoretic separation for the measurement of the isoenzyme composition of body fluids, e.g. hydroxybutyrate dehydrogenase determination (Rosalki and Wilkinson, 1960; Elliott and Wilkinson, 1961) , or urea inhibition (Hardy, 1965; Emerson and Wilkinson, 1965) for the preferential measurement of fast-moving L.D. isoenzymes and heat treatment of serum for the differentiation of liver from bone phosphatase (Posen et al., 1965) . 113 
Insoluble substrates
Insoluble substrates which liberate a soluble coloured product as the result of enzyme action have been used for many years in the determination of proteolytic enzymes. With early substrates the coloured component was in a state of physical absorption and this binding could be readily upset by non-enzymic factors, such as variation in the protein and salt concentration of the medium. Recently, however, interest in such substrates has been revived due to the introduction of amylose, covalently linked to remazolbrilliant blue, as an insoluble substrate for the determination of serum amylase (Rinderknecht et al., 1967) .
Insoluble substrates must generally be incubated with shaking, and then removed by precipitation, centrifugation or filtration from the solution into which they liberate their colour. Such shaking and removal are disadvantageous in the determination. However, one advantage in their use is their ability to serve as amplifying substrates, a single molar splitting causing the solubilisation of many moles of colour residues.
For amylase determination either dyed amylose or dyed amylo-pectin may be used as substrate. In addition, dyed amylose has been found to be a particularly suitable substrate for the demonstration of amylase isoenzymes (Rosalki, 1970) . A comparison of insoluble substrate amylase methods with saccharogenic and starch-iodine procedures is shown in Table 3 .
Screening methods
Rapid semi-quantitative screening methods for cholinesterase determination are available for the detection of serum cholinesterase deficiency in subjects exposed to organo-phosphorus insecticides or anti-cholinesterase compounds. A convenient procedure (Herzfeld and Stumpf, 1955) measures the time taken by a reagent-impregnated paper strip dipped in serum to turn from green to yellow. The paper strip is impregnated with a choline ester and bromothymol blue and the latter turns yellow as a result of liberation of acid from the ester by cholinesterase activity.
Semi-quantitative colorimetric diazo procedures which permit manual SGOT determinations on large numbers of samples (Whetzel, 1963) have been developed to facilitate the examination of blood donated for transfusion purposes, since it has been suggested that increased transaminase activity in the donor may predispose to an increased incidence of hepatitis in the recipient. Whilst this view is not 
Insoluble substrate methods
Saccharogenic methods Starch-iodine methods (e.g. Rinderknecht et al., 1967) (e.g. Somogyi, 1938) (e.g, Caraway, 1959) (Brandt et al., 1965) indicate a recipient incidence of hepatitis some 20 times higher following transfusion of blood from subjects showing transaminase elevation than from subjects with normal transaminase activity. The increasing use of automation and the adaptation of enzyme methodology to automated systems, permits enzyme screening to be included as part of chemical profile screening on hospital in-patients and on apparently healthy out-patients.
Such screening programmes now commonly include alkaline phosphatase, SGOT and L.D. determinations. Random screening for SGOT on both in-and out-patients has revealed an incidence of elevation approaching 2 %, liver disease generally accounting for the abnormality (Whitehead and Carmalt, 1969) . The incidence of alkaline phosphatase elevation is much higher than SGOT, approximating to 8 %; such elevation may result from bone or liver disease. There is considerable overlap between alkaline phosphatase and SGOT determination in liver disease, so that it is rare for SGOT to be elevated in the absence of a raised phosphatase.
ENZYME POLYMORPffiSMS
Genetically determined enzyme diversity amongst apparently healthy individuals has been established for many red cell and tissue enzymes. Such diversity has, for example, provided an explanation of the sensitivity of certain individuals to drug induced haemolytic anaemias. For serum enzymes, genetic polymorphism of cholinesterase and alkaline phosphatase have been noted and the relationship of such genetic diversity to disease evaluated.
For cholinesterase it has been shown that an extra electrophoretic fraction, whose presence is genetically determined, is present in 10% of the population (Harris et ai., 1963) and that such subjects show higher mean cholinesterase levels. Inhibitor studies show, in addition, that four alternative genes may operate at a genetic site (locus) for cholinesterase production which is separate from the locus for the production of the extra electrophoretic fraction (Kalow and Genest, 1957; Harris and Whittaker, 1961; Liddell, et al., 1962) . In homozygotes or heterozygotes in which the gene for the production of the usual types of cholinesterase is absent, serum cholinesterase activity is reduced. This is accompanied by enhanced sensitivity to suxamethonium muscle relaxant drugs used in anaesthesia, so that prolonged apnoea may result from their administration.
Serum alkaline phosphatase exhibits genetic polymorphism in respect of the presence and activity in serum of a component of intestinal origin. In normal subjects the presence of this intestinal enzyme is almost invariably associated with the secretion of H blood group antigens into the saliva and other body fluids and is more frequent in persons of blood group 0 and B (Arfors et al., 1963) . The level of the intestinal isoenzyme is influenced by diet and in fasting subjects it may be clearly detected by electrophoresis, only in group 0 and B secretor positive individuals. After meals containing fat, the activity in such subjects is increased but weak activity may also be detected in the serum of group A secretor positive subjects (Langman et al., 1966) .
The presence of the intestinal isoenzyme is associated with increased total serum alkaline phosphatase activity and increased heat stability (Fishman and Ghosh, 1967) . Because of the latter, it has been suggested that the heat stability test for the differentiation of bone and liver phosphatase may be refined by measuring the heat stability of the nonintestinal alkaline phosphatase of serum. This may be accomplished by the addition of L-phenylalanine to the phosphatase substrate, for L-phenylalanine is a specific inhibitor of intestinal phosphatase (Fishman et al., 1963) . However, in the author's experience, the procedure does not seem to be superior to the standard heat stability test.
A lowered level of intestinal alkaline phosphatase has been found in fibrocystic disease (Hsia et al., 1969) but since this is not associated with any alteration in blood group frequency, it is probably a secondary result of disturbed fat absorption rather than a specific genetic enzyme abnormality. Increased serum intestinal alkaline phosphatase levels have been noted in hepatic cirrhosis and in cancer patients (Fishman et al., 1965) .
It is clear that the investigation of genetic enzyme polymorphism may reveal the existence of further genetically controlled variants of serum enzymes. in the population. The study of these may provide an explanation of the differing responses both of the patient and of the serum enzymes to disease.
ENZYME BINDING BY SERUM PROTEINS
Some enzymes present in the serum are normally bound to protein, thus mitochondrial G.O.T., trypsin and chymotrypsin may be bound by a2-macroglobulin and this binding may facilitate enzyme transport and clearance (Boyde and Pryme, 1968) . Abnormal enzyme binding has also been described, particularly for L.D. and amylase. A thermostable high molecular weight L.D. isoenzyme has been observed in acute leukaemia, possibly a result of linkage to serum proteins (Lundh, 1967) ; binding of L.D. by myeloma protein has been noted; and broadening and retardation in electrophoretic mobility of all five L.D. isoenzymes due to their linkage with immunoglobulin A has been described lIS in systemic lupus erythematosis (Ganrot, 1967) . Whilst the protein-binding in these patients was probably secondary to the disease process, abnormal L.D. isoenzymes have also been noticed in a patient with myocardial infarction (Voigt, 1967) and in a subject with a fractured femur (Laurell, 1967) . In both, this was thought to be a genetic abnormality.
Binding of amylase to the serum globulins (Wilding et al., 1964) may result in high serum amylase levels due to inability of the kidney to excrete the resulting high molecular weight amylaseglobulin complex, a condition known as macroamylasaemia. Two varieties of the condition have been described. In one, the serum amylase is bound to immunoglobulin A and this is accompanied clinically by the malabsorption syndrome. In the other variety, malabsorption is absent and the amylase is not bound to immunoglobulin. In the first variety serum amylase activity may be reduced by precipitation of the amylase-immunoglobulin A complex by a specific anti-serum.
RENAL CLEARANCE OF SERUM ENZYMES IN KIDNEY DISEASE
The serum enzymes lysozyme and ribonuclease, both of very low molecular weight (about 15,(00), are normally filtered at the renal glomerulus and reabsorbed by the tubules, particularly the proximal tubules. Increased clearance of the enzyme provides evidence of proximal renal tubular damage (Harrison et al., 1968) . The serum amylase (molecular weight approx. 45,(00) does not appear to be reabsorbed by the tubules (Blainey and Northam, 1967) so that clearance of this enzyme reflects glomerular filtration.
The clearance of enzymes of different molecular weight may be used to assess the selectivity of tubular protein reabsorption. This may be valuable in the investigation of nephrosis, since in some nephrotics tubular reabsorption of protein becomes non-selective, and such cases generally respond poorly to steroid therapy.
The advantages of using enzymes for protein clearance studies over immunological methods of protein clearance determination are:
1. Ease of determination (e.g, no anti-sera preparation is necessary). 2. Sensitivity of determination-no concentration of urine being required, and 3. The accuracy that can be achieved in the determination.
